Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 13Gastrointestinal 13Thoracic 10Head & Neck 3Breast 2Tumor-Agnostic 1Other solid neoplasm 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Skin Neoplasms 1Inflammation 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tea × Dermatologic × Clear all
NCT01032031 2016-03-08

The Effect of Green Tea and Vitamin C on Skin Health

University of Manchester

Phase NA Completed
95 enrolled
Dermatologic

Inflammation, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡